Literature DB >> 5698585

The cachetic heart. A clinico-pathologic, electrocardiographic and roentgenographic entity.

G E Burch, J H Phillips, A Ansari.   

Abstract

Mesh：

Year:  1968        PMID： 5698585     DOI： 10.1378/chest.54.5.403

Source DB:  PubMed          Journal:  Dis Chest        ISSN： 0096-0217


× No keyword cloud information.
  17 in total

1.  Prostate cancer reduces endurance exercise capacity in association with reductions in cardiac and skeletal muscle mass in the rat.

Authors:  Peter J Esau; Elizabeth M Gittemeier; Alexander B Opoku-Acheampong; Korynne S Rollins; Dryden R Baumfalk; David C Poole; Timothy I Musch; Bradley J Behnke; Steven W Copp
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Cardiac Atrophy and Heart Failure In Cancer.

Authors:  Mark Sweeney; Angela Yiu; Alexander R Lyon
Journal:  Card Fail Rev       Date:  2017-04

3.  Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner.

Authors:  Pippa F Cosper; Leslie A Leinwand
Journal:  Cancer Res       Date:  2010-12-16       Impact factor: 12.701

Review 4.  Cardiac Complications: The Understudied Aspect of Cancer Cachexia.

Authors:  Vivek Bora; Bhoomika Patel
Journal:  Cardiovasc Toxicol       Date:  2022-02-16       Impact factor: 3.231

Review 5.  Nutrition challenges of cancer cachexia.

Authors:  Omnia U Gaafer; Teresa A Zimmers
Journal:  JPEN J Parenter Enteral Nutr       Date:  2021-11       Impact factor: 4.016

6.  Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart.

Authors:  Christian Mühlfeld; Suman Kumar Das; Frank R Heinzel; Albrecht Schmidt; Heiner Post; Silvia Schauer; Tamara Papadakis; Wolfgang Kummer; Gerald Hoefler
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

7.  Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.

Authors:  Vincenzo Musolino; Sandra Palus; Anika Tschirner; Cathleen Drescher; Micaela Gliozzi; Cristina Carresi; Cristiana Vitale; Carolina Muscoli; Wolfram Doehner; Stephan von Haehling; Stefan D Anker; Vincenzo Mollace; Jochen Springer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-04-07       Impact factor: 12.910

8.  Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia.

Authors:  Michaela Schäfer; Christian U Oeing; Maria Rohm; Ezgi Baysal-Temel; Lorenz H Lehmann; Ralf Bauer; H Christian Volz; Michael Boutros; Daniela Sohn; Carsten Sticht; Norbert Gretz; Katrin Eichelbaum; Tessa Werner; Marc N Hirt; Thomas Eschenhagen; Karin Müller-Decker; Oliver Strobel; Thilo Hackert; Jeroen Krijgsveld; Hugo A Katus; Mauricio Berriel Diaz; Johannes Backs; Stephan Herzig
Journal:  Mol Metab       Date:  2015-11-26       Impact factor: 7.422

9.  Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse.

Authors:  Nandini D P K Manne; M Lima; R T Enos; P Wehner; J A Carson; Eric Blough
Journal:  Int J Oncol       Date:  2013-04-11       Impact factor: 5.650

10.  Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist.

Authors:  Seyyed M R Kazemi-Bajestani; Harald Becher; Konrad Fassbender; Quincy Chu; Vickie E Baracos
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-03-14       Impact factor: 12.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.